Blood Transcript Analysis in Colorectal Cancer patients

Recruiting

• Conditions: 10017990; colon carcinoma

• Registration Number: NL-OMON43318
• Lead Sponsor: ederlands Kanker Instituut

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 375

Inclusion Criteria

1. Histologically confirmed colorectal cancer
2. Evaluable disease

Exclusion Criteria

1. Patients with non-invasive colorectal cancer.
2. Patients undergoing local excision for colorectal cancer.
3. Known history of HIV seropositivity.
4. Patient with other malignancies

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Blood CC12gene test signature to be an accurate test for diagnosis or for<br /><br>determination of status of disease and response to therapy with a sensitivity<br /><br>that exceeds that of current blood-based strategies (CEA).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>